Add To Favorites service@abbkine.com
Login Register
English
Chinese
Cart：(0)
0

Cart

$ 0

Technical

Recent articles

OR
Catalog no Product name Protocol name IF Magazine title
A01010 MiR-375 impairs the invasive capabilities of hepatoma cells by targeting HIF1α under hypoxia(A01010-3) 3 Digestive Diseases and Sciences
A23220 Dylight 488, Goat Anti-Rabbit IgG MiR-375 impairs the invasive capabilities of hepatoma cells by targeting HIF1α under hypoxia(A23220-3) 3 Digestive Diseases and Sciences
A25012 IPKine™ HRP, Goat Anti-Mouse IgG LCS MiR-375 impairs the invasive capabilities of hepatoma cells by targeting HIF1α under hypoxia(A25012-3) 3 Digestive Diseases and Sciences
A21020 HRP, Goat Anti-Rabbit IgG miR-383 reduces keratinocyte proliferation and induces the apoptosis in psoriasis via disruption of LCN2-dependent JAK/STAT pathway activation(A21020-4) 4 Int Immunopharmacol
PRP100263 Human IFN-γ protein miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition(PRP100263-4) 4 Scientific Reports
ABP50351 JNK1/2/3 (phospho Thr183/Y185) Polyclonal Antibody miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellularcarcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition(ABP50351-4) 4 Scientific Reports
ABP50669 miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellularcarcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition(ABP50669-4) 4 Scientific Reports
ABP51664 miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellularcarcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition(ABP51664-4) 4 Scientific Reports
A21020 HRP, Goat Anti-Rabbit IgG miR‑433 accelerates acquired chemoresistance of gallbladder cancer cells by targeting cyclin M(A21020-2) 2 Oncology Letters
ABP54978 AP-1 (phospho Ser243) Polyclonal Antibody miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellularcarcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition(ABP54978-4) 4 Scientific Reports
FirstPre329330331332333334335336337338339Next Last

RECEIVE OFFERS BY EMAIL

CONTACT US

Welcome any form of communications, and better service will be provided here.

Tell： +1-404-854-0155

Email： service@abbkine.com

Support Email： support@abbkine.com

Address： 3052 Stroop Hill Road, Apt 203, Atlanta 30303, Georgia, United States of America

Links：

Copyright © 2012 - 2017 Abbkine, Inc. - All rights reserved